Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CVS GroupCVSGF 90 EV-to-EBITDA is 10.06 as of Aug. 01, 2026, which is 36% below its 10-year median of 15.80. GuruFocus rates CVSGF with a GF Score™ of 90/100 and a GF Value™ of $16.86 (Fairly Valued). The stock has 4 warning signs investors should review. Among 509 Healthcare Providers & Services companies, CVS Group ranks better than 54.62% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, CVS Group's enterprise value is $1,503.7 Mil.
CVS Group's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was $149.5 Mil. Therefore, CVS Group's EV-to-EBITDA for today is 10.06.
The historical rank and industry rank for CVS Group's EV-to-EBITDA or its related term are showing as below:
CVSGF'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 7.2 Med: 15.8 Max: 31.69
Current: 9.94
During the past 13 years, the highest EV-to-EBITDA of CVS Group was 31.69. The lowest was 7.20. And the median was 15.80.
CVSGF's EV-to-EBITDA is ranked better than 54.62% of 509
companies
in the Healthcare Providers & Services industry
Industry Median: 11.04
vs CVSGF: 9.94
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
CVS Group's share price for today is $16.5312.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. CVS Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $0.933.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for CVS Group's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, CVS Group's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CVS Group EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, CVS Group's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where CVS Group's EV-to-EBITDA falls into.
CVS Group's current Enterprise Value is $1,503.7 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. CVS Group's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was $149.5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CVS Group (CVSGF) has a EV-to-EBITDA of 10.06 as of Aug. 01, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on CVS Group. This is 36% below median its historical median of 15.80. Over the past decade, CVS Group's EV-to-EBITDA has ranged from 7.20 to 31.69. According to the industry distribution chart, CVS Group ranks #231 out of 509 companies in the Healthcare Providers & Services industry, placing it in the top 45.4%.
Is CVS Group's EV-to-EBITDA too high?
CVS Group's current EV-to-EBITDA of 10.06 is 36% below median its 10-year median of 15.80. Over the past 10 years, this metric has ranged from a low of 7.20 to a high of 31.69. The Healthcare Providers & Services industry median EV-to-EBITDA is 11.04. CVS Group's value of 10.06 is 8.9% below this industry median. Based on the distribution chart, CVS Group ranks #231 out of 509 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, CVS Group has a GF Score™ of 90/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does CVS Group's EV-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, CVS Group ranks #231 out of 509 companies for EV-to-EBITDA. This puts CVS Group in the upper half of its industry. The industry median EV-to-EBITDA is 11.04. CVS Group's value of 10.06 is 8.9% below this benchmark. Historically, CVS Group's own EV-to-EBITDA has ranged from 7.20 to 31.69 over the past decade. While the company's 10-year median is 15.80 vs. the industry median of 11.04, CVS Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 11.04, based on 509 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CVS Group's current EV-to-EBITDA of 10.06 is 8.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on CVS Group. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 11.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CVS Group's current EV-to-EBITDA is 10.06, which is 36% below median its own 10-year median of 15.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CVS Group stock overvalued right now?
Based on GuruFocus' analysis, CVS Group (CVSGF) is currently considered Fairly Valued. The stock's GF Value™ is $16.86, compared to a current price of $16.53 — trading 2% below its estimated fair value. The current EV-to-EBITDA is 10.06, which is 36% below median its 10-year median of 15.80 and 8.9% below the Healthcare Providers & Services industry median of 11.04. CVS Group's overall GF Score™ is 90/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For CVS Group (CVSGF), the current EV-to-EBITDA is 10.06 as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CVS Group (CVSGF) Overvalued in 2026?
Based on GuruFocus' analysis, CVS Group stock appears to be undervalued.
The current stock price of $16.53 is trading 2% below its estimated GF Value™ of $16.86.
GuruFocus considers CVS Group to be Fairly Valued.
Key valuation signals for CVSGF:
EV-to-EBITDA: 10.06 (36% below median its 10-year median of 15.80)
GF Value™: $16.86 vs. price of $16.53 (2% below fair value)
Industry Position: 8.9% below the Healthcare Providers & Services median (#231 of 509)
No single metric tells the full story. See the CVSGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CVS Group PLC is a veterinary service provider in the United Kingdom. The group operates through three business divisions: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. The veterinary practice segment generates the majority of the revenues. The company facilitates its veterinary services through its diagnostics, laboratory reports, and pet cremation services. It also offers retail pharmacy through Animed Direct. Geographically, it generates the majority of its revenue from the United Kingdom and also operates in Australia.
90GF Score
Get the complete analysis for CVSGF
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CVSGF has been successfully added to your 
